NasdaqGS - Nasdaq Real Time Price
USD
Neumora Therapeutics, Inc. (NMRA)
0.5033
+0.0163
(+3.35%)
At close: November 6 at 4:00:00 PM EST
0.5200
+0.0167
(+3.32%)
After hours: November 6 at 6:12:45 PM EST
Trade NMRA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARCH VENTURE PARTNERS XII, LLC Beneficial Owner of more than 10% of a Class of Security |
Purchase | Oct 27, 2025 | -- |
| AURORA DALJIT SINGH Chief Operating Officer |
Conversion of Exercise of derivative security | Aug 21, 2026 | -- |
| BERNS PAUL L Chief Executive Officer |
Sale | Feb 17, 2026 | 7,794,480 |
| BUROW KRISTINA M Director and Beneficial Owner of more than 10% of a Class of Security |
Purchase | Oct 27, 2025 | -- |
| LENZ ROBERT A Officer |
Sale | Feb 18, 2025 | 309,092 |
| MILLIGAN MICHAEL LEE Chief Financial Officer |
Sale | Feb 17, 2026 | 21,034 |
| PINTO JOSHUA PH.D. President |
Sale | Feb 17, 2026 | 209,950 |
